The Medical College of Wisconsin (MCW) has received a four-year, $1.5 million grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases to study lymphocytes, the body’s “natural killer” cells, and determine the signaling pathways that elicit disease-fighting responses at a cellular level in the body.
Subramaniam Malarkannan, PhD, associate professor of medicine in the division of hematology and oncology, and an investigator at the Blood Research Institute, BloodCenter of Wisconsin, is the primary investigator of the grant.
The organization of signaling events in lymphocytes is not well understood. Hundreds of signaling molecules “share” information that results in cellular functions, but the precise mechanisms that coordinate that response remain an enigma.
Scaffolding proteins, which are crucial regulators of signaling pathways, provide part of the explanation. In this research project, Dr. Malarkannan will explore the role of a specific scaffolding protein called IQGAP1, which is hypothesized to function as a processing center, controlling multiple signaling pathways.
The ultimate goal of Dr. Malarkannan’s laboratory research is to specifically augment the cytotoxic potentials of human lymphocyte cells and utilize that potential to eliminate cancerous tumors in patients.
Your link to the biggest stories in the suburbs delivered Thursday mornings.
Enter your e-mail address above and click "Sign Up Now!" to begin receiving your e-mail newsletter Get the Newsletter!
- Member Companies Provide Support to Home Improvement Show
- The Challenge of Moving from a Home you Love
- Trinity UCC Jazz Worship & Luncheon
- Can social networks improve rates of treatment for HIV?
- SCORE announces February Business Training Schedule
- Puzzles Good for a Child’s Developing Brain
- Miss West Allis/New Berlin Scholarship Program
- Local Girl Wins Miss Wisconsin Collegiate Title
- Alverno College Exceeds $30 Million Capital Campaign Goal
- 16th Annual Reflections of Wellness for Women